Applications of Computational Chemistry in Drug Designing

Authors

  • Rohit Kumar Department of Chemistry, Annie Besant College of Engineering and Management, University of Lucknow, Lucknow, Uttar Pradesh, India

Abstract

Computational Chemistry in drug designing has played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based methods. Structure-based methods are in principle analogous to high-throughput screening in that both target and ligand structure information is imperative. Structure-based approaches include ligand docking, pharmacophore, and ligand design methods. The article discusses theory behind the most important methods and recent successful applications. Ligand-based methods use only ligand information for predicting activity depending on its similarity/dissimilarity to previously known active ligands. We review widely used ligand-based methods such as ligand-based pharmacophores, molecular descriptors, and quantitative structure-activity relationships. In addition, important tools such as target/ligand data bases, homology modeling, ligand fingerprint methods, etc., necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign are discussed. A wide range of illustrative applications, focusing on chemical materials are discussed briefly. Keywords: calculate structure, computational chemistry, drug designing, structures and properties of molecules and solids, theoretical chemistry

Author Biography

  • Rohit Kumar, Department of Chemistry, Annie Besant College of Engineering and Management, University of Lucknow, Lucknow, Uttar Pradesh, India
    Department of Chemistry, Annie Besant College of Engineering and Management, University of Lucknow, Lucknow, Uttar Pradesh, India

References

S. Wu-Pong, Y. Organismal.

Biopharmaceutical Drug Design and

Development. 2nd Edn. Totowa, NJ:

Humana Press, Humana Press;

ISBN 978-1-59745-532-9.

P. Imming, C. Sinning, A. Meyer.

Drugs, their targets and the nature and

number of drug targets, Nat Rev Drug

Discov. 2006; 5(10): 821–34p.

PMID17016423.

A.C. Anderson. The process of

structure-based drug design, Chem

Biol. 2003; 10(9): 787–97p.

PMID 14522049. doi:10.1016/j.chem

biol.2003.09.002.

W.F. de Azevedo, R. Dias.

Computational methods for

calculation of ligand-binding affinity,

Curr Drug Targets. 2008; 9(12):

–9p.

A.R. Leach, H. Jhoti. Structure-Based

Drug Discovery. Berlin: Springer;

ISBN 1-4020-4406-2.

H. Mauser, W. Guba. Recent

developments in de novo design and

scaffold hopping, Curr Opin Drug

Discov Dev. 2008; 11(3): 365–74p.

G. Klebe. Recent developments in

structure-based drug design, J Mol

Med. 2000; 78(5): 269–81p.

A.C. Anderson. The process of

structure-based drug design, Chem

Biol. 2003; 10(9): 787–97p.

Downloads

Published

2017-06-30

Issue

Section

Articles